Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,493 papers from all fields of science
Search
Sign In
Create Free Account
Sebacil
Known as:
Bayer brand of phoxim
, Sebacil Pour-on
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
phoxim
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
[Sarcoptes scabiei var. suis in a closed pig breeding and fattening herd and control possibilities after treatment].
M. Löwenstein
,
A. Ludin
,
Roman Peschke
,
H. Kahlbacher
,
M. Schuh
Berliner und Münchener tierärztliche…
2006
Corpus ID: 23202335
On an Austrian pig breeding and finishing farm containing 13,000 pigs a mange prevalence of 38.7% according to the results of the…
Expand
1999
1999
Efficacy of Sebacil pour-on (Bayer) in the treatment of sarcoptic mange in pigs
K. Rypua
,
A. Zalewski
,
K. Bulzacki
1999
Corpus ID: 198282768
1997
1997
Ocena skutecznosci preparatu Sebacil Pour-on [Bayer] w leczeniu swierzbu usznego u krolikow
M. Kamionowski
,
E. Kamionowska
,
Z. Nagórski
1997
Corpus ID: 179943404
1993
1993
Controlling ectoparasites of pigs by "Sebacil", a pour-on formulation of phoxim.
E. Müller
1993
Corpus ID: 53846835
1988
1988
Ectoparasite control in pigs with Sebacil by the pour-on procedure.
H. Dorn
,
E. Schein
,
A. Liebisch
1988
Corpus ID: 83210398
1980
1980
Contribution to the therapy for psoroptic and sarcoptic mange of various domestic animal species with the phosphoric acid ester Sebacil.
A. Liebisch
,
M. S. Rahman
,
A. Hassan
1980
Corpus ID: 82505873
1980
1980
Treatment of psoroptic and sarcoptic mange in various species of domestic animal with the phosphoric acid ester Sebacil (phoxim).
A. Liebisch
,
M. S. Rahman
,
A. Hassan
1980
Corpus ID: 83109075
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE